Selective cyclooxygenase-2 inhibitors: Belief, hope, reality!;Selektive cyclooxygenase-2-hemmer: Glaube, hoffnung, realitat!

Aktuelle Rheumatologie

Volumn 23, Issue 1, 1998, Pages 1-5

  Brune, K ^a,b   Hinz, B ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; INDOMETACIN; MELOXICAM; NONSTEROID ANTIINFLAMMATORY AGENT;

ANALGESIC ACTIVITY; ARTICLE; BLOOD CLOTTING DISORDER; DIGESTIVE SYSTEM ULCER; DRUG EFFECT; DRUG SELECTIVITY; HUMAN; KIDNEY INJURY; NONHUMAN;

EID: 0031951425     PISSN: 0341051X     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1043570     Document Type: Article

References (28)

1. Brune, K.: The early history of non-opoid analgesics. Acute Pain (1998) im Druck
2. Vane, J. R.: Inhibition of prostaglandin synthesis as a mechanism of action of aspirin-like drugs. Nature New Biol. 231 (1971) 232-235
3. Schmidt, R., M. Schmelz, C. Forster, M. Ringkamp, H. E. Torebjörk, H. O. Handwerker: Novel classes of responsive and unresponsive C nociceptors in human skin. J. Neurosci. 15 (1995) 333-341
4. Brune, K., M. Glatt, P. Graf: Mechanism of action of antiinflammatory drugs. Gen. Pharmacol. 7 (1976) 27-33
5. Israel, E., A. R. Fischer, M. A. Rosenberg, C. M. Lilly, J. C. Gallery, J. Shapiro, J. Cohn, P. Rubin, J. M. Drazen: The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Amer. Rev. Respir. Dis. 148 (1993) 1447-1451
6. Neugebauer, V., G. Schaible, X. He, T. Lücke, P. Gründling, R. F. Schmidt: Electrophysiological evidence for a spinal antinociceptive action of dipyrone. Agents Actions 41 (1994) 62-70
7. Shimada, S. G., I. G. Otterness, J. T. Stitt: A study of the mechanism of action of the mild analgesic dipyrone. Agents Actions 41 (1994) 188-192
8. Woolf, C. J.: A new strategy for the treatment of inflammatory pain. Prevention or elimination of central sensitization. Drugs 47 (Suppl. 5) (1994) 1-9
9. Yaksh, T. L., A. B. Malmberg: Spinal actions of NSAIDs in blocking spinally mediated hyperalgesia: the role of cyclooxygenase products. Agents Actions (Suppl. 41) (1993) 89-100
10. 2 synthase (cyclooxygenase) in human monocytes. J. Biol. Chem. 265 (1990) 16737-16740
11. Herschman, H. R.: Prostaglandin synthase 2. Biochim. Biophys. Acta 1299 (1996) 125-140
12. Vane, J.: Towards a better aspirin. Nature 367 (1994) 215-216
13. Laneuville, O., D. K. Breuer, D. L. Dewitt, T. Hla, C. D. Funk, W. L. Smith: Differential inhibition of human prostaglandin endoperoxide H synthases-1 and -2 by nonsteroid anti-inflammatory drugs. J. Pharmacol. Exp.Ther. 271 (1994) 927-934
14. Engelhardt, G., R. Bögel, C. Schnitzer, R. Utzmann: Meloxicam: influence on arachidonic acid metabolism; part I: in vitro findings. Biochem. Pharmacol. 51 (1996) 21-28
15. Meade, E. A., W. L. Smith, D. L. DeWitt: Differential inhibition of prostaglandin endoperoxide synthese (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J. Biol. Chem. 268 (1993) 6610-6614
16. Patrignani, P., M. R. Panara, A. Greco, O. Fusco, C. Natoli, S. Iacobelli, F. Cipollone, A. Ganci, C. Crèmion, J. Maclouf, C. Patrono: Biochemical and parmacological characterization of the cyclooxygenase activity of human blood prostaglandin endoper-oxide synthase. J. Pharmacol. Exp.Ther. 271 (1994) 1705-1712
17. Riendeau D.: Assays for the evaluation of selective COX-2 inhibitors on wild-type and mutated enzyme forms. First International Workshop on COX-2, Sept 13-14, 1997, New Orleans, Louisiana (Presentation Summaries)
18. Isakson, P. C.: Assessment of the selectivity of cyclooxygenase inhibitors. First International Workshop on COX-2, Sept 13-14, 1997, New Orleans, Louisiana (Presentation Summaries)
19. Beiche, F., S. Scheurer, K. Brune, G. Geisslinger, M. GoppeltStruebe: Upregulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 390 (1996) 165-169
20. Dinchuk, J. E., B. D. Car, R. J. Focht, J. J. Johnston, B. D. Jaffee, M. B. Covington, N. R. Contel, V. M. Eng, R. J. Collins, P. M. Czerniak, S. A. Corry, J. M. Trzaskos: Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II. Nature 378 (1995) 406-409
21. Bazan, N., G. Allan, V. Marcheselli: An inhibitor of injury-induced COX-2 transcriptional activation elicits neuroprotection in a brain damage model. In: Vane, J., J. Botting, R. Botting (Hrsg.): Improved non-steroid anti-inflammatory drugs. COX-2 enzyme inhibitors. Kluwer Academic Publishers Lancaster, William Harvey Press London (1996) 145-166
22. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87 (1996) 803-809
23. TOCCO, G., J. Freire-Moar, S. S. Schreiber, S. H. Sakhi, P. S. Aisen, G. M. Pasinetti: Maturational regulation and regional induction of cyclooxygenase-2 in rat brain: implications for Alzheimer's disease. Exp. Neurol. 144 (1997) 339-349
24. Brune, K., K. Wagner: The effect of protein/nucleic acid synthesis inhibitors on the inhibition of prostaglandin release from macrophages by dexamethasone. In: Brune, K., M. Baggiolini (Hrsg.): Arachidonic acid metabolism in inflammation and thrombosis. Agents Actions (Suppl. 4), Birkhäuser, Basel, Boston, Stuttgart (1979) 73-77
25. 2 by "lipocortins" and calpactins. An effect of binding to substrate phospholipids. J. Biol. Chem. 262 (1987) 1698-1705
26. Barnes, P. J., I. Adcock: Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol. Sci. 14 (1993) 436-441
27. Laporte, J. R., X. Carne, X. Vidal, V. Moreno, J. Juan: Upper gastrointestinal bleeding in relation to previous use of analgesics and non-steroidal anti-inflammatory drugs. Catalan countries study on upper gastrointestinal bleeding. Lancet 337 (1991) 85-89
28. Neupert, W., R. Brugger, C. Euchenhofer, K. Brune, G. Geisslinger: Effects of ibuprofen enantiomers and its coenzyme. A thioesters on human prostaglandin endoperoxide synthases. Brit. J. Pharmacol. 122 (1997) 487-492